BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18722669)

  • 21. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
    Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
    Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribavirin treatment for Crimean-Congo hemorrhagic fever.
    Leblebicioglu H
    Jpn J Infect Dis; 2009 Nov; 62(6):485-6; author reply 486. PubMed ID: 20058332
    [No Abstract]   [Full Text] [Related]  

  • 23. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
    Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
    J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethical concern.
    Doganci L
    J Infect; 2009 Oct; 59(4):289-90; author reply 290-1. PubMed ID: 19647019
    [No Abstract]   [Full Text] [Related]  

  • 25. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.
    Ergönül Ö; Keske Ş; Çeldir MG; Kara İA; Pshenichnaya N; Abuova G; Blumberg L; Gönen M
    Emerg Infect Dis; 2018 Sep; 24(9):1642-1648. PubMed ID: 30124196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment and prophylaxis with ribavirin for Crimean-Congo Hemorrhagic Fever--is it effective?
    Bangash SA; Khan EA
    J Pak Med Assoc; 2003 Jan; 53(1):39-41. PubMed ID: 12666854
    [No Abstract]   [Full Text] [Related]  

  • 27. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
    Duygu F; Kaya T; Baysan P
    Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection.
    Espy N; Pérez-Sautu U; Ramírez de Arellano E; Negredo A; Wiley MR; Bavari S; Díaz Menendez M; Sánchez-Seco MP; Palacios G
    J Infect Dis; 2018 May; 217(12):1952-1956. PubMed ID: 29584885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
    Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
    Oestereich L; Rieger T; Neumann M; Bernreuther C; Lehmann M; Krasemann S; Wurr S; Emmerich P; de Lamballerie X; Ölschläger S; Günther S
    PLoS Negl Trop Dis; 2014 May; 8(5):e2804. PubMed ID: 24786461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bradycardia related to ribavirin in four pediatric patients with Crimean-Congo hemorrhagic fever.
    Tezer H; Ozkaya Parlakay A; Gülhan B; Cetin I
    Vector Borne Zoonotic Dis; 2014 Jun; 14(6):464-5. PubMed ID: 24745325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of Crimean-congo hemorrhagic fever with pleural effusion.
    Tanir G; Tuygun N; Balaban I; Doksöz O
    Jpn J Infect Dis; 2009 Jan; 62(1):70-2. PubMed ID: 19168966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crimean-Congo hemorrhagic fever.
    Mardani M; Keshtkar-Jahromi M
    Arch Iran Med; 2007 Apr; 10(2):204-14. PubMed ID: 17367225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nosocomial outbreak of Crimean-Congo haemorrhagic fever.
    Naderi HR; Sarvghad MR; Bojdy A; Hadizadeh MR; Sadeghi R; Sheybani F
    Epidemiol Infect; 2011 Jun; 139(6):862-6. PubMed ID: 20800007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose methylprednisolone in children with Crimean-Congo haemorrhagic fever.
    Dilber E; Cakir M; Erduran E; Koksal I; Bahat E; Mutlu M; Celtik AY; Okten A
    Trop Doct; 2010 Jan; 40(1):27-30. PubMed ID: 20075424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia.
    Papa A; Bozovi B; Pavlidou V; Papadimitriou E; Pelemis M; Antoniadis A
    Emerg Infect Dis; 2002 Aug; 8(8):852-4. PubMed ID: 12141973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotoxic effect of ribavirin in patients with Crimean-Congo hemorrhagic fever.
    Tatar A; Ozkurt Z; Kiki I
    Jpn J Infect Dis; 2005 Oct; 58(5):313-5. PubMed ID: 16249628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crimean-Congo hemorrhagic fever in Southeast of Iran.
    Alavi-Naini R; Moghtaderi A; Koohpayeh HR; Sharifi-Mood B; Naderi M; Metanat M; Izadi M
    J Infect; 2006 May; 52(5):378-82. PubMed ID: 16182370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells.
    Andersson I; Lundkvist A; Haller O; Mirazimi A
    J Med Virol; 2006 Feb; 78(2):216-22. PubMed ID: 16372299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do we really need ribavirin in the treatment of crimean-congo hemorrhagic Fever?
    Kalın G; Metan G; Demiraslan H; Doganay M
    J Chemother; 2014 Jun; 26(3):146-9. PubMed ID: 24091085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.